312 related articles for article (PubMed ID: 24459782)
21. Applying Quality by Design Concepts to Pharmacy Compounding.
Timko RJ
Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
[TBL] [Abstract][Full Text] [Related]
22. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
Minghetti P; Pantano D; Gennari CG; Casiraghi A
Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
[TBL] [Abstract][Full Text] [Related]
23. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
Pritchett J; Mixon W; O'Connell K
Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
[TBL] [Abstract][Full Text] [Related]
24. Drug product quality.
Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
[No Abstract] [Full Text] [Related]
25. Basics of compounding: repackaging, part 2.
Allen LV
Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
[TBL] [Abstract][Full Text] [Related]
26. Compounding in Ukraine.
Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
[TBL] [Abstract][Full Text] [Related]
27. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
[TBL] [Abstract][Full Text] [Related]
28. Compounding errors.
Drazen JM; Curfman GD; Baden LR; Morrissey S
N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
[No Abstract] [Full Text] [Related]
29. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
30. IACP's 2016 Compounders on Capitol Hill Asks.
Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
[No Abstract] [Full Text] [Related]
31. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
32. Regulators faulted for inadequate compounding pharmacy oversight.
Traynor K
Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
[No Abstract] [Full Text] [Related]
33. Lawmakers get big picture on pharmacy issues.
Kertesz L
AHIP Cover; 2008; 49(6):10, 67, 69. PubMed ID: 19180929
[No Abstract] [Full Text] [Related]
34. Compounding pharmacies: who is in charge?
Pergolizzi JV; Labhsetwar S; LeQuang JA
Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
[TBL] [Abstract][Full Text] [Related]
35. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
[No Abstract] [Full Text] [Related]
36. Controlled substances in long-term care pharmacy: part 2.
Martin CM
Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
[TBL] [Abstract][Full Text] [Related]
37. Compounding pharmacy: old methods finding a new niche.
Matheny C; Martin CM
Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
[TBL] [Abstract][Full Text] [Related]
38. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
Battaglino G
Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
[No Abstract] [Full Text] [Related]
39. Looking for solutions.
Menighan TE
Int J Pharm Compd; 2013; 17(1):4. PubMed ID: 23627240
[No Abstract] [Full Text] [Related]
40. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
